Institution statistics

MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN - Germany

Ranking results:

Past rankings:

2019
Criterium:	Position:
Overall Score:	> 1000
Total Number of Projects:	600-700
2018
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	600-700
Networking Rank (Reputation):	> 1000
2016
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 21
As coordinator: 1
As participant: 20
Sole participant: 0
Coordinator / Participant Ratio: 0.05^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2019	0	77.525.204	0		5
2018	0	30.751.188	505.577		4
2017	3.556.208	23.549.833	1.471.729	1	2
2016	0	21.066.307	750.570		5
2010	0	23.073.794	184.549		1
2004	0	12.000.000	521.739		1
2002	0	2.799.997	466.666		1
2000	0	1.600.659	200.082		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
JANSSEN PHARMACEUTICA NV	9
NOVARTIS PHARMA	8
KATHOLIEKE UNIVERSITEIT LEUVEN	7
ELI LILLY AND COMPANY LIMITED	5
F HOFFMANNLA ROCHE	5
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT	5
PFIZER LIMITED	5
BAYER AKTIENGESELLSCHAFT	4
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	4
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER	4
MERCK SHARP & DOHME CORP	4
SANOFIAVENTIS	4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	4
UCB BIOPHARMA	4
ABBVIE INC	3
AMGEN LIMITED	3
ASTRAZENECA AB	3
BAYER	3
COVANCE LABORATORIES	3
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE	3
EUROPEAN PATIENTS' FORUM	3
GRUNENTHAL	3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	3
INSTITUT DE RECHERCHES SERVIER	3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	3
NOVO NORDISK	3
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT	3
TAKEDA DEVELOPMENT CENTRE EUROPE	3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	3
UNIVERSITY OF NEWCASTLE UPON TYNE	3
ARKEMA FRANCE	2
ASTELLAS PHARMA EUROPE BV	2
ASTRAZENECA	2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS	2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	2
CONSIGLIO NAZIONALE DELLE RICERCHE	2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	2
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON	2
EUROPEAN CANCER PATIENT COALITION	2
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE	2
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES	2
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG	2
H LUNDBECK AS	2
INTERUNIVERSITAIR MICRO ELECTRONICA CENTRUM VZW	2
OLEON NV	2
OWKIN FRANCE	2
PROCESS DESIGN CENTER BV	2
SANOFIAVENTIS DEUTSCHLAND	2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL	2
SYNCOM BV	2
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	2
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY	2
THE SYNERGIST	2
THE UNIVERSITY OF MANCHESTER	2
UNIVERSITAET ZUERICH	2
UNIVERSITATSKLINIKUM ERLANGEN	2
UNIVERSITE DE GENEVE	2
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK	2
UNIVERSITY OF BIRMINGHAM	2
UNIVERSITY OF BOLOGNA	2
UNIVERSITY OF DURHAM	2
UNIVERSITY OF OSLO	2
UPPSALA UNIVERSITET	2
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV	2
ABBVIE	1
ACADEMISCH ZIEKENHUIS GRONINGEN	1
ACCELOPMENT	1
ACTA	1
ACTELION PHARMACEUTICALS	1
AGENZIA ITALIANA DEL FARMACO	1
AGENZIA REGIONALE DI SANITA	1
AIXTRON	1
ALEXION SERVICES EUROPE SPRL	1
ALZHEIMER EUROPE	1
AMGEN	1
AMGEN RESEARCH	1
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA	1
ATMEL GRENOBLE	1
AYMING	1
BASF AKTIENGESELLSCHAFT	1
BASF SE	1
BAYER PHARMA	1
BAYERISCHE FORSCHUNGSALLIANZ BAVARIAN RESEARCH ALLIANCE	1
BIOASCENT DISCOVERY LIMITED	1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM	1
BIONOTUS	1
BIOSCI CONSULTING BVBA	1
BKW BIOKRAFTWERKE FUERSTENWALDE	1
BLUEBIRD BIO INC	1
BORREGAARD INDUSTRIES LIMITED	1
BRISTOLMYERS SQUIBB COMPANY CORP	1
BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS	1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL	1
CELGENE MANAGEMENT SARL	1
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD	1
CENTRE DE RECHERCHE PUBLIC DE LA SANTE	1
CENTRE DE REGULACIO GENOMICA	1
CENTRE FOR RENEWABLE ENERGY SOURCESAND SAVING FONDATION	1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER	1

Constancy:

Total number of partners:449

Partner loyalty:
Frequent Partner: (> 2 projects): 124
Rare Partner: 325

Frequent / Rare Partner Ratio: 0.38

Diversity:

Subjects:

Subject:	No:
INFORMATION PROCESSING	3
INFORMATION SYSTEMS	3
TECHNOLOGY TRANSFER	2
INNOVATION	2
INFORMATION PROCESSING, INFORMATION SYSTEMS	2
INNOVATION, TECHNOLOGY TRANSFER	1
BIOFUELS	1
SUSTAINABLE DEVELOPMENT	1

Diversity index:0.21

Categories:

Category:	No:
INDUSTRY AND TECHNOLOGY	3
RTD HORIZONTAL TOPICS	2
ENERGY	1
PROTECTING MAN AND HIS ENVIRON	1

Project overview:

Start date	Project	acronym	role	funding	partners
2019-12-01	Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies	imSAVAR	participant	10.999.316	28
2019-06-01	MachinE Learning Ledger Orchestration for Drug DiscoverY	MELLODDY	participant	8.000.000	17
2019-04-01	Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement	MOBILISE-D	participant	25.395.897	34
2019-04-01	Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation	ConcePTION	participant	15.299.991	53
2019-03-01	Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts	IMMUcan	participant	17.830.000	28
2018-12-01	European Screening Centre; Unique Library for Attractive Biology	ESCulab	participant	18.249.993	20
2018-11-01	Chemical Engineering Immersive Learning	CHARMING	participant	4.060.228	13
2018-10-01	Using the smart matrix approach to enhance TADF-OLED efficiency and lifetime	TADFlife	participant	3.942.037	21
2018-03-01	Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.	PARADIGM	participant	4.498.931	34
2017-09-01	Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management	eTRANSAFE	participant	20.000.000	27
2017-02-01	Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055	DO-IT	participant	3.549.833	36
2017-01-01	Development of high-performance, hyperfluorescence OLEDs for use in display applications and solid state lighting	HyperOLED	coordinator	3.556.208	5
2016-10-01	Continuous Resolution and Deracemization of Chiral Compounds by Crystallization	CORE	participant	3.920.690	15
2016-10-01	Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966	PREFER	participant	6.000.000	33
2016-09-01	Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network	SYNTRAIN	participant	3.990.269	13
2016-05-01	Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines	PEARRL	participant	3.856.253	10
2016-02-01	Production technology to achieve low Cost and Highly Efficient phOtovoltaic Perovskite Solar cells	CHEOPS	participant	3.299.095	12
2010-03-01	EUROpean multilevel integrated BIOREFinery design for sustainable biomass processing	EuroBioRef	participant	23.073.794	34
2004-10-01	Organic LEDs for ICT and Lighting Applications	OLLA	participant	12.000.000	23
2002-04-01	Liquid Crystal On Silicon For Low Cost Optical Systems	LCOS4LCOS	participant	2.799.997	6
2000-11-01	Colour Research for Outdoor Matrix liquid crystal display Applied To Electronic Advertising and Message boards	CROMATEAM	participant	1.600.659	8

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum